Targeted Cancer Therapy in Biomedical Engineering
Targeted Cancer Therapy in Biomedical Engineering
YOU SAVE £22.36
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
- More about Targeted Cancer Therapy in Biomedical Engineering
This book highlights the role of Biomedical Engineering (BME) in diagnosis and treatment of cancer, with a focus on the expansion of biomedical microdevices. It discusses the advancements and innovations in BME that improve targeted delivery for cancer therapeutics, such as particles, targeting moieties, and stimuli-responsive drug release mechanisms. It is a useful resource for students, researchers, and professionals in BME and medicine.
Format: Hardback
Length: 941 pages
Publication date: 12 April 2023
Publisher: Springer Verlag, Singapore
This comprehensive book delves into the profound impact of biomedical engineering (BME) in the realm of diagnosis and treatment, particularly in combating cancer. Through the use of advanced body scanners and radiation therapy, BME plays a pivotal role in identifying and addressing various diseases. In recent years, remarkable progress has been made in expanding biomedical microdevices, which have assumed a critical role in cancer diagnosis and therapy.
When it comes to fighting cancer, both efficacy and speed are of paramount importance. A groundbreaking microfluidic chip has recently emerged, enabling researchers to test the effectiveness of specialized cancer drugs with unprecedented precision. This breakthrough has the potential to revolutionize the field of cancer treatment by providing valuable insights into drug efficacy.
To achieve effective cancer-targeting therapies, a combination of passive and active targeting strategies is necessary, along with a deep understanding of the physiological barriers that hinder targeted drug delivery. The development of targeted cancer treatments and the implementation of new combinatorial approaches hold great promise for improving targeted anticancer drug delivery and ultimately enhancing treatment outcomes.
This book serves as a valuable resource for students, researchers, and professionals in the fields of BME and medicine. It explores the advancements and innovations in BME that have contributed to improving the diagnosis and treatment of cancer. Specifically, it focuses on bioengineering approaches to enhance targeted delivery for cancer therapeutics, encompassing particles, targeting moieties, and stimuli-responsive drug release mechanisms. By unraveling these complex mechanisms, the book provides insights into the latest developments in the field and offers practical applications for the development of more effective cancer treatments.
Weight: 1604g
Dimension: 235 x 155 (mm)
ISBN-13: 9789811997853
Edition number: 1st ed. 2023
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.